Bioceres Crop Solutions Corp. (BIOX) Q4 2026 Earnings Call Transcript
Bioceres Crop Solutions faces significant headwinds as its core Argentine agricultural markets drive a 25.5% year-over-year revenue contraction observed in 2026Q2. The company's financial stability is increasingly compromised by an eroding equity base, which h...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 14, 2026 | -$0.39-542.0% vs -$0.06 | $56M-29.2% vs $79M |
Q2 2026 May 11, 2026 | -$0.16-220.0% vs -$0.05 | $39M-27.7% vs $55M |
Q2 2026 Mar 13, 2026 | -$0.08-214.3% vs $0.07 | $74M-23.3% vs $96M |
Q4 2025 Nov 13, 2025 | -$0.12-200.0% vs -$0.04 | $78M-18.1% vs $95M |
Bioceres Crop Solutions Corp. (BIOX) Q4 2026 Earnings Call Transcript
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2026. A press release detailing these resul.
Pinnacle Food Group (NASDAQ: PFAI - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is
Benchmark BIOX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Bioceres Crop Solutions Corp. (BIOX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.34 | $21.18M | -0.41 | -28.3% | -15.54% | -16.02% | — | |
| $7.89 | $2.81B | -5.60 | 146.73% | -183.98% | -498.32% | — | |
| $10.57 | $1.32B | -0.59 | -18.34% | -84.83% | -117.23% | — | |
| $80.28 | $53.69B | 50.18 | 2.92% | 5.66% | 4.04% | — | |
| $2.09 | $59.79M | -1.19 | -5.88% | -10.7% | -27.84% | — | |
| $115.13 | $13.66B | 44.97 | 37.55% | 24.86% | 180.63% | — |
Bioceres Crop Solutions Corp. (BIOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BIOX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Bioceres Crop Solutions Corp. (BIOX) stock FAQ — growth, dividends, profitability & financials explained
Bioceres Crop Solutions Corp. (BIOX) reported $285.1M in revenue for fiscal year 2025. This represents a 204% increase from $93.7M in 2017.
Bioceres Crop Solutions Corp. (BIOX) saw revenue decline by 28.3% over the past year.
Bioceres Crop Solutions Corp. (BIOX) reported a net loss of $236.0M for fiscal year 2025.
Bioceres Crop Solutions Corp. (BIOX) has a return on equity (ROE) of -16.0%. Negative ROE indicates the company is unprofitable.
Bioceres Crop Solutions Corp. (BIOX) generated $68.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.